4//SEC Filing
Scott Randal W. 4
Accession 0001209191-23-048595
CIK 0001743881other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:00 PM ET
Size
5.7 KB
Accession
0001209191-23-048595
Insider Transaction Report
Form 4
Scott Randal W
Director
Transactions
- Sale
Common Stock
2023-09-05$30.00/sh−2,500$75,000→ 13,500 total(indirect: See Footnote)
Holdings
- 5,000
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.
- [F2]By Thinking Bench Capital LLC.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001337801
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:00 PM ET
- Size
- 5.7 KB